In this study, we hypothesized that it would be possible to use a bespoke genetic workflow to classify patients with BD into three broad categories: (i) monogenic BD or BD mimic; (ii) HLA-B*51-positive BD; or (iii) HLA-B*51-negative BD. The gene discussed is HLA-B; the disease is Behcet disease.